CoChat

West Nile Virus Economic Impact, Louisiana, 2002

Open access
Zohrabian, Armineh, Meltzer, Martin I., Ratard, Raoult, Billah, Kaafee, Molinari, Noelle A., Roy, Kakoli, Scott, R. Douglas, Petersen, Lyle R. · 2004 · Emerging Infectious Diseases
Cited by 76

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

West Nile virus (WNV) is transmitted by mosquitoes and can cause illness in humans ranging from mild fever to encephalitis.In 2002, a total of 4,156 WNV cases were reported in the United States; 329 were in Louisiana.To estimate the economic impact of the 2002 WNV epidemic in Louisiana, we collected data from hospitals, a patient questionnaire, and public offices.Hospital charges were converted to economic costs by using Medicare cost-tocharge ratios.The estimated cost of the Louisiana epidemic was $20.1 million from June 2002 to February 2003, including a $10.9 million cost of illness ($4.4 million medical and $6.5 million nonmedical costs) and a $9.2 million cost of public health response.These data indicate a substantial short-term cost of the WNV disease epidemic in Louisiana. W est Nile virus (WNV) is transmitted by mosquitoesand can cause illnesses ranging from simple fevers to encephalitis (1).The presence of this virus in the Western Hemisphere was first recognized in New York City in 1999 (2).In 2002, an epidemic of WNV illness focused in the midwestern United States resulted in 4,156 reported cases; 2,942 cases had central nervous system (CNS) illness (meningitis, encephalitis, or acute flaccid paralysis), and 284 died (3).A total of 329 persons with WNV disease were reported in Louisiana, with illness onsets from June to November.Among these, 204 had illnesses involving the CNS; 24 died (Louisiana Office of Public Health, unpub.data).Economic data about epidemics are essential for estimating the costs and benefits of strengthening and maintaining prevention and control programs, improving existing surveillance systems, and introducing other proposed interventions, such as vaccines.Although some estimates exist of the economic impact imposed by diseases transmitted by mosquitoes (4-9), to our knowledge, no previous studies have assessed the costs of a WNV disease epidemic.We estimated the magnitude of the short-term economic costs of the 2002 WNV epidemic in Louisiana. Economic Model, Data, and MethodsWe calculated the costs of the WNV epidemic as the sum of 1) medical costs (inpatient and outpatient); 2) nonmedical costs, such as productivity losses caused by illness and premature death, costs of transportation for a patient to visit a healthcare provider, and childcare expenses; and 3) costs incurred by public health and other government agencies for epidemic control.Data were gathered from hospitals in Louisiana that had WNV patients; a phone survey of WNV patients (all adult patients with nonfatal cases for whom phone numbers were available from the Louisiana Office of Public Health were included in the survey); and public offices, including the Louisiana Office of Public Health, state and local governments, and the Louisiana Office of Emergency Preparedness.Because information could not be gathered for all hospitalized patients and the patient questionnaire could not be administered to all reported patients, we extrapolated cost data, assuming that the costs for those with information were representative of those without information (the extrapolation method is described in Appendix 1).We took a societal perspective, evaluating all costs regardless of who bore them.The costs were estimated from June 2002, when the epidemic was first recognized, until the last date we administered the phone survey, February 27, 2003, some 3 months after the onset of illness of the last reported patient.Intangible costs, attributable to factors such as pain and suffering, were not included.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid1010.030925

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 20

  1. Marfin, 2001, West Nile encephalitis: an emerging disease in the United States., Clin Infect Dis, 33, 1713, 10.1086/322700 · DOI · Paper page
  2. Nash, 2001, The outbreak of West Nile virus infection in the New York City area in 1999., N Engl J Med, 344, 1807, 10.1056/NEJM200106143442401 · DOI · Paper page
  3. O'Leary, 2004, The epidemic of West Nile virus in the United States, 2002., Vector Borne Zoonotic Dis, 4, 61, 10.1089/153036604773083004 · DOI · Paper page
  4. Schwab, 1968, Economic cost of St. Louis encephalitis epidemic in Dallas, Texas, 1966., Public Health Rep, 83, 860, 10.2307/4593433 · doi:10.2307/4593433
  5. Utz, 2003, Economic and social impacts of La Crosse encephalitis in western North Carolina., Am J Trop Med Hyg, 69, 509, 10.4269/ajtmh.2003.69.509 · DOI
  6. Villari, 1995, The economic burden imposed by a residual case of eastern encephalitis., Am J Trop Med Hyg, 52, 8, 10.4269/ajtmh.1995.52.8 · DOI · Paper page
  7. Meltzer, 1998, Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984–1994., Am J Trop Med Hyg, 59, 265, 10.4269/ajtmh.1998.59.265 · DOI · Paper page
  8. Gallup, 2001, The economic burden of malaria., Am J Trop Med Hyg, 64, 85, 10.4269/ajtmh.2001.64.85 · DOI · Paper page
  9. Meltzer, 2001, Introduction to health economics for physicians., Lancet, 358, 993, 10.1016/S0140-6736(01)06107-4 · DOI · Paper page
  10. 2001, Statewide average operating cost-to-charge ratios for urban and rural hospitals (case weighted) March 2001 (Table 8A)., Fed Regist, 66, 22845
  11. Molinari NA. Efficiency improvements via monitoring in medical groups [dissertation]. Detroit (MI): Wayne State University; 2001.
  12. Grosse SD. Appendix I. Productivity loss tables. In: Haddix AC, Teutsch SM, Corso PS, editors. Prevention effectiveness. 2nd ed. New York: Oxford University Press; 2003. p. 255–7.
  13. Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, eds. Prevention effectiveness. 1st ed. New York: Oxford University Press; 1996. p. 188.
  14. Arias E. United States life tables, 2000. National vital statistics reports, vol. 51, no. 3. Hyattsville (MD): Department of Health and Human Services; 2002. p. 8.
  15. Corso PS, Haddix AC. Time Effects. In: Haddix AC, Teutsch SM, Corso PS, editors. Prevention effectiveness. 2nd ed. New York: Oxford University Press; 2003. p. 94–5 · DOI · Paper page
  16. Petersen, 2003, West Nile virus., JAMA, 290, 524, 10.1001/jama.290.4.524 · DOI · Paper page
  17. Haddix AC, Corso PS, Gorsky RD. Costs. In Haddix AC, Teutsch SM, Corso PS, editors. Prevention effectiveness. 2nd ed. New York: Oxford University Press; 2003. p.70–1. · DOI · Paper page
  18. Meltzer, 2001, Introduction to health economics for physicians., Lancet, 358, 993, 10.1016/S0140-6736(01)06107-4 · DOI · Paper page
  19. Corso PS, Haddix AC. Time effects. In: Haddix AC, Teutsch SM, Corso PS, editors. Prevention effectiveness. 2nd ed. New York: Oxford University Press; 2003. p. 94–5. · DOI · Paper page
  20. Arias E. United States life tables, 2000. National vital statistics reports, vol. 51, no. 3. Hyattsville (MD): Department of Health and Human Services; 2002. p. 8.

Cited by

See all 76

Metadata

Authors
Zohrabian, A., Meltzer, M. I., Ratard, R., Billah, K., Molinari, N. A., Roy, K., Scott, R. D., & Petersen, L. R.
Venue
Emerging Infectious Diseases
Published
2004-10
Volume
10
Issue
10
Pages
1736-1744
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W2021934723
Cited by
76
References
2
FWCI
6.38
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.